Dianthus price target raised to $132 from $110 at Jefferies
positive target upgrade
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
positive target upgrade
What happened, with direct paths to the underlying reporting
Jefferies raises Dianthus Therapeutics (DNTH) price target to $132 from $110; current price around $76.42.
Target: $132
Posted price: $76.42
Analyst firm: Jefferies
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.